Singapore markets open in 8 hours 21 minutes

InVivo Therapeutics Holdings Corp. (04I.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
0.25450.0000 (0.00%)
At close: 08:21AM CET
Full screen
Previous close0.2545
Bid0.0000 x N/A
Ask0.0000 x N/A
Day's range0.2545 - 0.2545
52-week range0.1360 - 1.9800
Avg. volume2,631
Market cap846,739
Beta (5Y monthly)0.66
PE ratio (TTM)N/A
EPS (TTM)-3.0300
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Business Wire

    InVivo Therapeutics Announces Topline Data from Pivotal INSPIRE 2.0 Study in Acute Spinal Cord Injury

    CAMBRIDGE, Mass., March 09, 2023--InVivo Therapeutics Holdings Corp. (Nasdaq: NVIV), a research and clinical-stage biomaterials and biotechnology company with a focus on the treatment of spinal cord injuries (SCI), today announced topline results from the company’s INSPIRE 2.0 study, which was designed to evaluate the safety and probable benefit of InVivo’s investigational Neuro-Spinal Scaffold™, a bioresorbable scaffold-based device in development for patients with acute SCI. The study did not